BREAST CANCER SCREENING PROGRAMME

Reporting year for qualitative data:	2016
Source of qualitative data:	Other (EU Report 2017)

Organization of screening
An individual/team/institution responsible to coordinate the programme:	-
Dedicated budget for screening programme:	-
Documented cancer screening policy:	Yes
Nature of documentation of the policy:	Recommendation
Year programme was initiated:	No data submitted
Programme introduction was preceded by a pilot:	-
Screening tests provided free of charge:	-
Diagnostic tests provided free of charge:	-
Treatment services provided free of charge:	-
Information system and data collection
System that collects data:
• Identification of eligible population:	-
• Screening participation:	-
• Screening test results:	-
• Further assessment:	-
• Final pathology diagnosis:	-
• Cancer staging:	-
• Treatment:	-
The information system exists at national or sub-national level:	Individual: Unknown Aggregated: Unknown
The information system collects data outside the programme (opportunistic screening/private sector):	-
Cancer screening data is linked with population-based cancer registry (PBCR):	-
Screening protocol
A screening protocol or guideline:	-
Year of published/updated protocol:	-
Target age (min-max) and screening interval [months] for each test:	Mammography/DBT + CBE/US (40- years / [24 months])
All mammograms read by two radiologists independently:	-
Invitations for screening and further assessment
Initiatives to create population awareness by the Health Ministry/Health Authority:	-
Invitations to eligible population:	-
Source of the eligible individuals identified:	-
Method of invitation:	-
Screen positive individuals actively contacted for further assessment:	-
Individuals with a precancer or cancer diagnosis actively contacted:	-
Quality Assurance (QA) of screening activities
Documented standard operating procedure/policy for QA:	-
An individual/team/institution responsible for QA:	-
Accreditation of mammography units:	-
Accreditation of pathology services:	-
Documented performance indicators:	-
Reference standards for performance indicators:	-
Evaluation reports published in the last five years:	-
Performance indicators
Reporting year for quantitative data:	2016
Source of quantitative data:	Report (EU Report 2017)
Age range and regional limitation if applicable:
Invitation coverage (%):
Participation rate (%):
Examination coverage (%):
Completeness of data related to screening test results (%):
Completeness of data related to further assessment results (%):
Further assessment rate (%):
Further assessment participation rate (%):
Detection rate of CIS (x 1000):
Detection rate of invasive cancer (x 1000):
Detection rate of CIS and invasive cancer (x 1000):
Positive Predictive Value of abnormal screening test to detect CIS (x 1000):
Positive Predictive Value of invasive cancer (x 1000):
Positive Predictive Value of CIS and invasive cancer (x 1000):
More quantitative data (2013)

Check also the following factsheets: Greece, Cervical, Colorectal